
Marcia Stephens Noble
Examiner (ID: 19297, Phone: (571)272-5545 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1632 |
| Total Applications | 1089 |
| Issued Applications | 595 |
| Pending Applications | 110 |
| Abandoned Applications | 393 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14342845
[patent_doc_number] => 20190153395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => SYSTEMS AND METHODS FOR GROWTH OF INTESTINAL CELLS IN MICROFLUIDIC DEVICES
[patent_app_type] => utility
[patent_app_number] => 16/074747
[patent_app_country] => US
[patent_app_date] => 2017-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37551
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074747
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/074747 | Systems and methods for growth of intestinal cells in microfluidic devices | Jan 31, 2017 | Issued |
Array
(
[id] => 16663237
[patent_doc_number] => 10932454
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-02
[patent_title] => LDL receptor gene knockout, genetically-engineered hamster
[patent_app_type] => utility
[patent_app_number] => 16/074768
[patent_app_country] => US
[patent_app_date] => 2017-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 10
[patent_no_of_words] => 6869
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074768
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/074768 | LDL receptor gene knockout, genetically-engineered hamster | Jan 31, 2017 | Issued |
Array
(
[id] => 16681915
[patent_doc_number] => 10941382
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-09
[patent_title] => Platelet production promoter and method of producing platelets using same
[patent_app_type] => utility
[patent_app_number] => 16/071598
[patent_app_country] => US
[patent_app_date] => 2017-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 7
[patent_no_of_words] => 8082
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16071598
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/071598 | Platelet production promoter and method of producing platelets using same | Jan 29, 2017 | Issued |
Array
(
[id] => 14407461
[patent_doc_number] => 20190169574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => IN VITRO PRODUCTION OF PANCREATIC BETA CELLS
[patent_app_type] => utility
[patent_app_number] => 16/074870
[patent_app_country] => US
[patent_app_date] => 2017-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7976
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074870
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/074870 | IN VITRO PRODUCTION OF PANCREATIC BETA CELLS | Jan 24, 2017 | Abandoned |
Array
(
[id] => 11618407
[patent_doc_number] => 20170128594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-11
[patent_title] => 'Humanized Viral Vectors and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 15/411489
[patent_app_country] => US
[patent_app_date] => 2017-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 15715
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15411489
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/411489 | Humanized viral vectors and methods of use thereof | Jan 19, 2017 | Issued |
Array
(
[id] => 11670303
[patent_doc_number] => 20170159023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'NOVEL LOW-MOLECULAR-COMPOUND FOR IMPROVING PRODUCTION, MAINTENANCE AND PROLIFERATION OF PLURIPOTENT STEM CELLS, COMPOSITION COMPRISING THE SAME, AND CULTURE METHOD'
[patent_app_type] => utility
[patent_app_number] => 15/411642
[patent_app_country] => US
[patent_app_date] => 2017-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 19679
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15411642
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/411642 | Low-molecular-compound for improving production, maintenance and proliferation of pluripotent stem cells, composition comprising the same, and culture method | Jan 19, 2017 | Issued |
Array
(
[id] => 13837533
[patent_doc_number] => 20190022251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => Adeno-Associated Virus Virions for Treatment of Epilepsy
[patent_app_type] => utility
[patent_app_number] => 16/069370
[patent_app_country] => US
[patent_app_date] => 2017-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10890
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16069370
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/069370 | Adeno-Associated Virus Virions for Treatment of Epilepsy | Jan 12, 2017 | Abandoned |
Array
(
[id] => 13774699
[patent_doc_number] => 20190000888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => CARDIOSPHERE-DERIVED CELLS AND EXOSOMES SECRETED BY SUCH CELLS IN THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION
[patent_app_type] => utility
[patent_app_number] => 16/066014
[patent_app_country] => US
[patent_app_date] => 2017-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13816
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16066014
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/066014 | Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction | Jan 10, 2017 | Issued |
Array
(
[id] => 11963825
[patent_doc_number] => 20170267978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'INDUCED PLURIPOTENT STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/403653
[patent_app_country] => US
[patent_app_date] => 2017-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 14511
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15403653
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/403653 | INDUCED PLURIPOTENT STEM CELLS | Jan 10, 2017 | Abandoned |
Array
(
[id] => 14277831
[patent_doc_number] => 20190136200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => Cellular Reprogramming Utilizing mRNA
[patent_app_type] => utility
[patent_app_number] => 16/068469
[patent_app_country] => US
[patent_app_date] => 2016-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13042
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16068469
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/068469 | Cellular Reprogramming Utilizing mRNA | Dec 28, 2016 | Abandoned |
Array
(
[id] => 11757500
[patent_doc_number] => 20170204368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'DERIVATION OF EMBRYONIC STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/390319
[patent_app_country] => US
[patent_app_date] => 2016-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6095
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15390319
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/390319 | DERIVATION OF EMBRYONIC STEM CELLS | Dec 22, 2016 | Abandoned |
Array
(
[id] => 15604279
[patent_doc_number] => 10583180
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-10
[patent_title] => Method for treating adenosine deaminase severe combined imunodeficiency
[patent_app_type] => utility
[patent_app_number] => 15/383030
[patent_app_country] => US
[patent_app_date] => 2016-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 83
[patent_no_of_words] => 32611
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15383030
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/383030 | Method for treating adenosine deaminase severe combined imunodeficiency | Dec 18, 2016 | Issued |
Array
(
[id] => 14665493
[patent_doc_number] => 10370637
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-06
[patent_title] => Technology for sustaining pluripotency and improved growth of stem cells in culture
[patent_app_type] => utility
[patent_app_number] => 15/380811
[patent_app_country] => US
[patent_app_date] => 2016-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4588
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15380811
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/380811 | Technology for sustaining pluripotency and improved growth of stem cells in culture | Dec 14, 2016 | Issued |
Array
(
[id] => 12541575
[patent_doc_number] => 10010058
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-03
[patent_title] => Transgenic animal for production of antibodies having minimal CDRS
[patent_app_type] => utility
[patent_app_number] => 15/377940
[patent_app_country] => US
[patent_app_date] => 2016-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 18633
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 252
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15377940
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/377940 | Transgenic animal for production of antibodies having minimal CDRS | Dec 12, 2016 | Issued |
Array
(
[id] => 11514303
[patent_doc_number] => 20170081377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-23
[patent_title] => 'RTEF-1 VARIANTS AND THE USE THEREOF FOR INHIBITION OF ANGIOGENESIS'
[patent_app_type] => utility
[patent_app_number] => 15/369583
[patent_app_country] => US
[patent_app_date] => 2016-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 22000
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15369583
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/369583 | RTEF-1 variants and the use thereof for inhibition of angiogenesis | Dec 4, 2016 | Issued |
Array
(
[id] => 15383969
[patent_doc_number] => 10533157
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-01-14
[patent_title] => Recombinant NK cells expressing co-stimulatory molecules
[patent_app_type] => utility
[patent_app_number] => 15/366838
[patent_app_country] => US
[patent_app_date] => 2016-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5882
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15366838
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/366838 | Recombinant NK cells expressing co-stimulatory molecules | Nov 30, 2016 | Issued |
Array
(
[id] => 13533809
[patent_doc_number] => 20180318447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-08
[patent_title] => COMPOSITIONS AND METHODS FOR IMPROVING VIRAL VECTOR EFFICIENCY
[patent_app_type] => utility
[patent_app_number] => 15/772902
[patent_app_country] => US
[patent_app_date] => 2016-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13209
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15772902
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/772902 | Compositions and methods for improving viral vector efficiency | Nov 29, 2016 | Issued |
Array
(
[id] => 11514566
[patent_doc_number] => 20170081640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-23
[patent_title] => 'COMBINED CHEMICAL AND GENETIC APPROACHES FOR GENERATION OF INDUCED PLURIPOTENT STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/365823
[patent_app_country] => US
[patent_app_date] => 2016-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 29040
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15365823
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/365823 | Combined chemical and genetic approaches for generation of induced pluripotent stem cells | Nov 29, 2016 | Issued |
Array
(
[id] => 14039327
[patent_doc_number] => 20190075770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => GENETIC MODIFICATION NON-HUMAN ORGANISM, EGG CELLS, FERTILIZED EGGS, AND METHOD FOR MODIFYING TARGET GENES
[patent_app_type] => utility
[patent_app_number] => 16/061769
[patent_app_country] => US
[patent_app_date] => 2016-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17139
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16061769
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/061769 | GENETIC MODIFICATION NON-HUMAN ORGANISM, EGG CELLS, FERTILIZED EGGS, AND METHOD FOR MODIFYING TARGET GENES | Nov 28, 2016 | Abandoned |
Array
(
[id] => 11497800
[patent_doc_number] => 20170071985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'EXTRACELLULAR MATRIX COMPOSITIONS FOR THE TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/362261
[patent_app_country] => US
[patent_app_date] => 2016-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17889
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15362261
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/362261 | Extracellular matrix compositions for the treatment of cancer | Nov 27, 2016 | Issued |